Benjamin Berger
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Neurology top 2%
- Myasthenia Gravis and Thymoma
- Autoimmune Neurological Disorders and Treatments
- Peripheral Neuropathies and Disorders
Papers in
- Neurology 31
- Autoimmune Neurological Disorders and Treatments 17
- Myasthenia Gravis and Thymoma 9
- Peripheral Neuropathies and Disorders 3
-
- Tryptophan and brain disorders 6
- Co-authors
- Oliver Stich (20 shared papers)Sebastian Rauer (15 shared papers)Rick S. Dersch (14 shared papers)Dominique Endres (26 shared papers)Tilman Hottenrott (11 shared papers)Ludger Tebartz van Elst (20 shared papers)Annette Baumgärtner (4 shared papers)Kathrin Nickel (15 shared papers)
In The Last Decade
Benjamin Berger
56 papers receiving 1.1k citations
Benjamin Berger's Hit Papers
Peers
Comparison fields: 5 of 73
- Biological Psychiatry 65
- Neurology 566
- Pathology and Forensic Medicine 187
- Neurology 47
- Hepatology 36
Countries citing papers authored by Benjamin Berger
This map shows the geographic impact of Benjamin Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Berger more than expected).
Fields of papers citing papers by Benjamin Berger
This network shows the impact of papers produced by Benjamin Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Berger. The network helps show where Benjamin Berger may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study Hit paper breakdown → | 2023 | 178 |
| 2 | 2022 | 80 | |
| 3 | 2015 | 64 | |
| 4 | 2021 | 54 | |
| 5 | 2013 | 44 | |
| 6 | 2015 | 36 | |
| 7 | 2016 | 36 | |
| 8 | 2020 | 36 | |
| 9 | 2022 | 36 | |
| 10 | 2022 | 33 | |
| 11 | 2015 | 32 | |
| 12 | 2017 | 31 | |
| 13 | 2021 | 27 | |
| 14 | 2021 | 25 | |
| 15 | 2018 | 24 | |
| 16 | 2016 | 23 | |
| 17 | 2020 | 23 | |
| 18 | 2019 | 18 | |
| 19 | 2022 | 18 | |
| 20 | 2016 | 17 |
About Benjamin Berger
Benjamin Berger is a scholar working on Neurology, Biological Psychiatry, Pathology and Forensic Medicine, Hepatology and Psychiatry and Mental health, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Autoimmune Neurological Disorders and Treatments (17 papers), Multiple Sclerosis Research Studies (10 papers), Myasthenia Gravis and Thymoma (9 papers), Tryptophan and brain disorders (6 papers), Hepatitis Viruses Studies and Epidemiology (4 papers), Peripheral Neuropathies and Disorders (3 papers), Schizophrenia research and treatment (2 papers) and Sepsis Diagnosis and Treatment (2 papers). The work is most often cited by research in Biological Psychiatry (65 citations), Neurology (566 citations), Pathology and Forensic Medicine (187 citations), Neurology (47 citations) and Hepatology (36 citations). Benjamin Berger has collaborated with scholars based in Germany and Sweden. Frequent co-authors include Oliver Stich, Sebastian Rauer, Rick S. Dersch, Dominique Endres, Tilman Hottenrott, Ludger Tebartz van Elst, Annette Baumgärtner, Kathrin Nickel, Kimon Runge and Katharina Domschke. Their work appears in journals such as Journal of the Neurological Sciences, Journal of Neurology, BMC Neurology, Journal of Neuroimmunology and Fluids and Barriers of the CNS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.